Bausch + Lomb Corp · Q4 2022 earnings

Briefing

Bausch + Lomb reported mixed results for Q4 2022, with revenues in line with the previous year but a net loss reported. The company highlighted organic revenue growth across all segments and progress in its separation from Bausch Health.

Bausch + Lomb's Q4 2022 revenues were $996 million, in line with Q4 2021. The company reported a GAAP net loss of $1 million, and adjusted EBITDA was $181 million. Organic revenue grew by 5%, driven by growth across all segments. The company is undergoing a CEO transition, with Brent Saunders set to take over in March 2023.

• Revenues of $996 million were in line with the fourth quarter of 2021.
• GAAP net loss attributable to Bausch + Lomb Corporation was $1 million.
• Adjusted EBITDA (non-GAAP) was $181 million.
• Organic revenues grew 5%, driven by organic growth across all segments.

Headline financials

Revenue & EPS history

Bausch + Lomb will provide expectations on its first-quarter 2023 outlook during the call today at 8 a.m. ET; however, given the appointment of Mr. Saunders as CEO and chair of the Board, effective March 6, 2023, the Company will provide full guidance for 2023 when it provides first-quarter 2023 results.